|
CA2156836A1
(en)
|
1993-03-18 |
1994-09-29 |
Janusz Jozef Kulagowski |
Benzimidazole derivatives
|
|
GB9305641D0
(en)
|
1993-03-18 |
1993-05-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
GB9305623D0
(en)
|
1993-03-18 |
1993-05-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US5763263A
(en)
|
1995-11-27 |
1998-06-09 |
Dehlinger; Peter J. |
Method and apparatus for producing position addressable combinatorial libraries
|
|
US6960589B2
(en)
|
2001-03-09 |
2005-11-01 |
Abbott Laboratories |
Benzimidazoles that are useful in treating sexual dysfunction
|
|
EP1435947B1
(en)
|
2001-10-19 |
2007-08-15 |
Ortho-McNeil Pharmaceutical, Inc. |
2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
|
|
US20040127504A1
(en)
|
2002-09-06 |
2004-07-01 |
Cowart Marlon D. |
Benzimidazoles that are useful in treating sexual dysfunction
|
|
MXPA05011539A
(es)
|
2003-04-30 |
2006-01-23 |
Inst For Pharm Discovery Inc |
Acidos carboxilicos sustituidos con heterociclo como inhibidores de la proteina tirosina-fosfatasa-1b.
|
|
WO2007117399A2
(en)
|
2006-03-31 |
2007-10-18 |
Janssen Pharmaceutica N.V. |
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
|
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
WO2010115736A2
(en)
|
2009-04-02 |
2010-10-14 |
Merck Serono S.A. |
Dihydroorotate dehydrogenase inhibitors
|
|
EP2414348B1
(en)
|
2009-04-03 |
2013-11-20 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
|
|
MA34300B1
(fr)
|
2010-05-13 |
2013-06-01 |
Amgen Inc |
Composés azotés hétérocycliques convenant comme inhibiteurs de la pde10
|
|
HRP20251088T1
(hr)
|
2012-07-01 |
2025-11-07 |
Novo Nordisk A/S |
Upotreba dugodjelujućih peptida glp‑1
|
|
WO2015166398A1
(en)
|
2014-04-30 |
2015-11-05 |
Aurigene Discovery Technologies Limited |
3h-imidazo[4,5-b]pyridine derivatives as dihydroorotate dehydrogenase inhibitors
|
|
JOP20190060A1
(ar)
|
2016-09-26 |
2019-03-26 |
Chugai Pharmaceutical Co Ltd |
مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1
|
|
EP3555064B9
(en)
|
2016-12-16 |
2023-03-01 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|
|
JP7461104B2
(ja)
|
2017-11-29 |
2024-04-03 |
中外製薬株式会社 |
Ｇｌｐ－１受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物
|
|
CA3045644C
(en)
|
2018-06-13 |
2024-01-16 |
Pfizer Inc. |
Glp-1 receptor agonists and uses thereof
|
|
ES2943510T3
(es)
|
2018-06-15 |
2023-06-13 |
Pfizer |
Agonistas del receptor GLP-1 y usos del mismo
|
|
TWI705820B
(zh)
|
2018-06-22 |
2020-10-01 |
美商美國禮來大藥廠 |
Gip/glp1促效劑組合物
|
|
CR20210110A
(es)
|
2018-08-31 |
2021-05-13 |
Pfizer |
Combinaciones para tratamiento de ehna/ehgna y enfermedades relacionadas
|
|
CR20210341A
(es)
|
2018-11-22 |
2021-11-25 |
Qilu Regor Therapeutics Inc |
Agonistas de glp-ir y usos de los mismos
|
|
AU2020256647B2
(en)
|
2019-04-12 |
2025-07-31 |
Qilu Regor Therapeutics Inc. |
GLP-1R agonists and uses thereof
|
|
TWI751585B
(zh)
|
2019-06-28 |
2022-01-01 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
WO2021018023A1
(zh)
*
|
2019-08-01 |
2021-02-04 |
济南泰达领创医药技术有限公司 |
小分子glp-1受体调节剂
|
|
CA3157525A1
(en)
|
2019-10-25 |
2021-04-29 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
KR20210059584A
(ko)
|
2019-11-15 |
2021-05-25 |
일동제약(주) |
Glp-1 수용체 작용제 및 이의 용도
|
|
JP7386997B2
(ja)
|
2019-11-15 |
2023-11-27 |
イルドン ファーマシューティカル カンパニー リミテッド |
Ｇｌｐ－１受容体アゴニストおよびその使用
|
|
KR20210069000A
(ko)
|
2019-12-02 |
2021-06-10 |
현대약품 주식회사 |
Glp-1 수용체 작용제
|
|
MX2022007105A
(es)
|
2019-12-10 |
2022-07-11 |
Pfizer |
Formas solidas de sal de 1,3-dihidroxi-2-(hidroximetil)propan-2-am ina de acido 2-((4-((s)-2-(5-cloropiridin-2-il)-2-metilbenzo[d][1, 3] dioxol-4-il)piperidin-1-il)metil)-1-(((s)-oxetan-2-il) metil)-1h- benzo[d]imidazol-6-carboxilico.
|
|
WO2021154796A1
(en)
|
2020-01-29 |
2021-08-05 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
CN119841865A
(zh)
|
2020-02-07 |
2025-04-18 |
加舒布鲁姆生物公司 |
杂环glp-1激动剂
|
|
WO2021160127A1
(en)
|
2020-02-13 |
2021-08-19 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
MY207021A
(en)
|
2020-03-18 |
2025-01-24 |
Lg Chemical Ltd |
Glp-1 receptor agonist, pharmaceutical composition comprising same, and method for preparing same
|
|
EP4125896B1
(en)
|
2020-03-27 |
2025-05-07 |
Pfizer Inc. |
Treatment of type 2 diabetes with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof
|
|
TW202144340A
(zh)
|
2020-04-03 |
2021-12-01 |
大陸商江蘇恆瑞醫藥股份有限公司 |
稠合咪唑類衍生物、其製備方法及其在醫藥上的應用
|
|
CN113493447B
(zh)
|
2020-04-03 |
2024-06-11 |
轩竹(北京)医药科技有限公司 |
Glp-1受体激动剂
|
|
FI4143183T3
(fi)
|
2020-04-29 |
2026-01-07 |
Gasherbrum Bio Inc |
Heterosyklisiä glp-1-agonisteja
|
|
FI4157832T3
(fi)
|
2020-05-27 |
2024-08-29 |
Qilu Regor Therapeutics Inc |
Glp-1r-agonistien suola- ja kidemuotoja ja niiden käyttötarkoituksia
|
|
PH12022553313A1
(en)
|
2020-06-04 |
2023-04-12 |
Hangzhou Sciwind Biosciences Co Ltd |
Five-membered heteroaromatic imidazole compound and use thereof
|
|
CN111548311B
(zh)
|
2020-06-04 |
2021-04-23 |
山西医科大学 |
一种小分子glp-1r激动剂及其应用
|
|
US20230234968A1
(en)
|
2020-06-10 |
2023-07-27 |
Medshine Discovery Inc. |
Methyl-substituted benzobisoxazole compound and use thereof
|
|
WO2021254470A1
(zh)
|
2020-06-19 |
2021-12-23 |
江苏恒瑞医药股份有限公司 |
6-氧代-3,6-二氢吡啶类衍生物、其制备方法及其在医药上的应用
|
|
WO2021259309A1
(zh)
|
2020-06-24 |
2021-12-30 |
广州市恒诺康医药科技有限公司 |
Glp-1受体激动剂及其药物组合物和用途
|
|
WO2022017338A1
(en)
|
2020-07-20 |
2022-01-27 |
Eccogene (Shanghai) Co., Ltd. |
Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same
|
|
TW202214622A
(zh)
|
2020-08-06 |
2022-04-16 |
大陸商上海齊魯銳格醫藥研發有限公司 |
Ｇｌｐ－１ｒ促效劑及其用途
|
|
PE20231181A1
(es)
|
2020-08-06 |
2023-08-11 |
Gasherbrum Bio Inc |
Agonistas del glp-1 heterociclicos
|
|
PE20231206A1
(es)
|
2020-08-21 |
2023-08-17 |
Terns Pharmaceuticals Inc |
Compuestos como agonistas de glp-1r
|
|
WO2022042691A1
(en)
|
2020-08-28 |
2022-03-03 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
AU2021306414B2
(en)
|
2020-09-01 |
2026-01-29 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
Fused imidazole derivative, preparation method therefor, and medical use thereof
|
|
WO2022048665A1
(en)
|
2020-09-07 |
2022-03-10 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
EP4211139A4
(en)
|
2020-09-10 |
2024-12-18 |
Gasherbrum Bio, Inc. |
HETEROCYCLIC GLP-1 AGONISTS
|
|
WO2022068772A1
(zh)
|
2020-09-29 |
2022-04-07 |
深圳信立泰药业股份有限公司 |
一种苯并咪唑类衍生物及其制备方法和医药用途
|
|
EP4227299A4
(en)
|
2020-10-12 |
2025-04-09 |
Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. |
GLP-1 RECEPTOR AGONIST, BENZIMIDAZOLONE AND ITS USE
|
|
EP4229050A4
(en)
*
|
2020-10-13 |
2024-12-11 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
JP2023546054A
(ja)
|
2020-10-13 |
2023-11-01 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
TWI912388B
(zh)
|
2020-10-14 |
2026-01-21 |
大陸商上海齊魯銳格醫藥研發有限公司 |
Ｇｌｐ-１ｒ促效劑的晶型及其用途
|
|
EP4247804A1
(en)
|
2020-11-20 |
2023-09-27 |
Gilead Sciences, Inc. |
Polyheterocyclic glp-1 r modulating compounds
|
|
US20240246959A1
(en)
|
2020-11-27 |
2024-07-25 |
Shenzhen Salubris Pharmaceuticals Co., Ltd. |
Benzimidazole derivative and preparation method therefor and medical use thereof
|
|
CN114591308B
(zh)
|
2020-12-03 |
2024-03-08 |
苏州闻泰医药科技有限公司 |
一类glp-1r受体激动剂化合物及其用途
|
|
WO2022135572A1
(zh)
|
2020-12-25 |
2022-06-30 |
四川海思科制药有限公司 |
一种五并五元环衍生物及其在医药上的应用
|
|
CA3209593A1
(en)
|
2021-01-28 |
2022-08-04 |
Carmot Therapeutics, Inc. |
Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
|
|
WO2022192430A1
(en)
|
2021-03-11 |
2022-09-15 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
EP4304711A1
(en)
|
2021-03-11 |
2024-01-17 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
WO2022199661A1
(en)
*
|
2021-03-24 |
2022-09-29 |
Eccogene (Shanghai) Co., Ltd. |
Phenyl- [1, 3] dioxolo [4, 5-c] pyridinyl-phenyl-, phenyl- [1, 3] dioxolo [4, 5-c] pyridinyl-heteroaryl-, or phenyl- [1, 3] dioxolo [4, 5-c] pyridinyl-piperidinyl-methyl-oxetanylmethyl-1h-benzo [d] imidazole-carboxylic acid derivatives and methods of using same
|
|
WO2022202864A1
(ja)
|
2021-03-24 |
2022-09-29 |
塩野義製薬株式会社 |
縮合環を有するｇｌｐ－１受容体作動薬を含有する医薬組成物
|
|
ES2925124B2
(es)
|
2021-03-29 |
2024-04-08 |
Fundacion Univ San Antonio |
Tratamiento de la obesidad
|
|
WO2022216094A1
(ko)
|
2021-04-08 |
2022-10-13 |
주식회사 엘지화학 |
Glp-1 수용체 효능제, 이를 포함하는 약학적 조성물 및 이의 제조방법
|
|
WO2022219495A1
(en)
|
2021-04-12 |
2022-10-20 |
Novartis Ag |
2-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesity
|
|
PH12023552860A1
(en)
|
2021-04-21 |
2024-05-20 |
Gilead Sciences Inc |
Carboxy-benzimidazole glp-1r modulating compounds
|
|
WO2022228490A1
(zh)
|
2021-04-30 |
2022-11-03 |
上海翰森生物医药科技有限公司 |
多环类衍生物调节剂、其制备方法和应用
|
|
WO2022235717A1
(en)
|
2021-05-03 |
2022-11-10 |
Carmot Therapeutics, Inc. |
Benzimidazoyl glp-1 receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
|
|
BR112023023276A2
(pt)
|
2021-05-07 |
2024-01-30 |
Alx Oncology Inc |
Derivados de exatecan e conjugados anticorpo-fármaco destes
|
|
TWI843104B
(zh)
|
2021-05-20 |
2024-05-21 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
KR20240021212A
(ko)
|
2021-06-10 |
2024-02-16 |
안타그 테라퓨틱스 에이피에스 |
비만 및 비만-관련 장애의 치료
|
|
WO2022268152A1
(zh)
|
2021-06-24 |
2022-12-29 |
杭州中美华东制药有限公司 |
Glp-1受体激动剂及其组合物和用途
|
|
WO2023001237A1
(en)
|
2021-07-21 |
2023-01-26 |
Hepagene Therapeutics (HK) Limited |
Glucagon-like peptide-1 receptor modulators and uses thereof
|
|
CN113480534B
(zh)
|
2021-07-23 |
2022-05-13 |
广州必贝特医药股份有限公司 |
苯并咪唑或氮杂苯并咪唑-6-羧酸类化合物及其应用
|
|
EP4382525A4
(en)
|
2021-08-04 |
2025-07-16 |
Shanghai Hansoh Biomedical Co Ltd |
CYCLOALKENE DERIVATIVE REGULATOR, PREPARATION METHOD AND USE THEREOF
|
|
US20240366639A1
(en)
|
2021-08-12 |
2024-11-07 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
JP2024532619A
(ja)
|
2021-08-27 |
2024-09-05 |
バーサニス バイオ、インコーポレイテッド |
併用療法
|
|
IL310377A
(en)
|
2021-08-30 |
2024-03-01 |
Mindrank Ai Ltd |
Novel aryl ether substituted heterocyclic compound as glp1r agonist
|
|
CN117940422A
(zh)
|
2021-08-31 |
2024-04-26 |
辉瑞大药厂 |
2-[(4-{6-[(4-氰基-2-氟芐基)氧基]吡啶-2-基}哌啶-1-基)甲基]-1-[(2s)-氧杂环丁烷-2-基甲基]-1h-苯并咪唑-6-羧酸，1,3-二羟基-2-(羟甲基)丙-2-胺盐的固体形式
|
|
WO2023038039A1
(ja)
|
2021-09-08 |
2023-03-16 |
塩野義製薬株式会社 |
抗肥満作用の関与する疾患の予防及び治療用医薬
|
|
JP2024536869A
(ja)
|
2021-09-27 |
2024-10-08 |
ヤンセン ファーマシューティカ エヌ．ベー． |
イミダゾピリダジンｉｌ－１７阻害剤化合物
|
|
KR20240068737A
(ko)
|
2021-09-27 |
2024-05-17 |
테른스 파마슈티칼스, 인크. |
Glp-1r 효능제로서의 벤즈이미다졸 카복실산
|
|
AU2022358915A1
(en)
|
2021-10-05 |
2024-05-09 |
Astrazeneca Ab |
Certain 2,5-diazabicyclo[4.2.0]octanes as glp-1 receptor modulators
|
|
WO2023057429A1
(en)
|
2021-10-05 |
2023-04-13 |
Astrazeneca Ab |
Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
|
|
WO2023057414A1
(en)
|
2021-10-05 |
2023-04-13 |
Astrazeneca Ab |
Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
|
|
TWI843243B
(zh)
|
2021-10-22 |
2024-05-21 |
大陸商盛世泰科生物醫藥技術（蘇州）股份有限公司 |
作為glp-1受體激動劑的化合物、包含其的藥物組成物及其用途
|
|
AU2022375634A1
(en)
|
2021-10-25 |
2024-06-06 |
Terns Pharmaceuticals, Inc. |
Compounds as glp-1r agonists
|
|
JPWO2023106310A1
(https=)
|
2021-12-07 |
2023-06-15 |
|
|
|
CN114280573B
(zh)
|
2021-12-09 |
2025-09-26 |
上海禾赛科技有限公司 |
激光雷达及其测量目标反射率的方法和系统
|
|
WO2023111145A1
(en)
|
2021-12-16 |
2023-06-22 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
US20250066338A1
(en)
|
2021-12-16 |
2025-02-27 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
WO2023124824A1
(zh)
|
2021-12-29 |
2023-07-06 |
海思科医药集团股份有限公司 |
一种glp-1激动剂的盐及其晶型和在医药上的应用
|
|
EP4469444A4
(en)
|
2022-01-24 |
2026-01-07 |
Gasherbrum Bio Inc |
GLP-1 HETEROCYCLIC AGONISTS
|
|
CN119343343A
(zh)
|
2022-02-09 |
2025-01-21 |
加舒布鲁姆生物公司 |
杂环glp-1激动剂
|
|
WO2023151575A1
(en)
|
2022-02-09 |
2023-08-17 |
Gasherbrum Bio Inc. |
Heterocyclic glp-1 agonists
|
|
EP4476212A1
(en)
|
2022-02-10 |
2024-12-18 |
Novartis AG |
2-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesity
|
|
KR20240150488A
(ko)
|
2022-02-23 |
2024-10-15 |
테른스 파마슈티칼스, 인크. |
Glp-1r 작용제로서의 화합물
|
|
CN119137124A
(zh)
|
2022-03-09 |
2024-12-13 |
加舒布鲁姆生物公司 |
杂环glp-1激动剂
|
|
WO2023179542A1
(en)
|
2022-03-21 |
2023-09-28 |
Gasherbrum Bio , Inc. |
5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes
|
|
WO2023198140A1
(en)
|
2022-04-14 |
2023-10-19 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
CN114716423A
(zh)
|
2022-05-20 |
2022-07-08 |
中国科学院上海药物研究所 |
5,6-二氢-1,2,4-三嗪类化合物及其作为glp-1受体激动剂的药学用途
|
|
US20250136584A1
(en)
|
2022-05-20 |
2025-05-01 |
Chengdu Di'ao Jiuhong Pharmaceutical Factory |
Benzimidazole Or Azabenzimidazole Compound, Preparation Method Therefor And Use Thereof
|
|
WO2024041609A1
(zh)
|
2022-08-24 |
2024-02-29 |
广州市联瑞制药有限公司 |
苯并双环类化合物及其制备方法和应用
|
|
CN119894885A
(zh)
|
2022-08-30 |
2025-04-25 |
广州市联瑞制药有限公司 |
苯并双环类化合物及其制备方法和应用
|
|
WO2024051700A1
(zh)
|
2022-09-05 |
2024-03-14 |
德睿智药(苏州)新药研发有限公司 |
作为glp1r激动剂的新型芳基氘代苄醚取代杂环类化合物
|
|
US20260097037A1
(en)
|
2022-09-22 |
2026-04-09 |
Shionogi & Co., Ltd. |
Fused ring compound having glp-1 receptor agonist effect
|
|
JPWO2024063140A1
(https=)
|
2022-09-22 |
2024-03-28 |
|
|
|
WO2024102625A1
(en)
|
2022-11-11 |
2024-05-16 |
Eli Lilly And Company |
Glucagon-like peptide 1 receptor agonists
|
|
IL320810A
(en)
|
2022-11-16 |
2025-07-01 |
Lilly Co Eli |
Glucagon-like peptide 1 receptor agonists
|
|
JP2026501285A
(ja)
|
2022-12-22 |
2026-01-14 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環式ｇｌｐ－１アゴニスト
|
|
JP2026500865A
(ja)
|
2023-01-13 |
2026-01-08 |
中国科学院上海薬物研究所 |
Ｇｌｐ－１受容体アゴニストとして使用される４－アルコキシベンゾイミダゾール－６－カルボン酸誘導体
|
|
WO2024206647A1
(en)
|
2023-03-29 |
2024-10-03 |
Terns Pharmaceuticals, Inc. |
Polymorphic forms and salts of a glp-1r agonist
|
|
US20240368120A1
(en)
|
2023-03-29 |
2024-11-07 |
Terns Pharmaceuticals, Inc. |
Compounds as glp-1r agonists
|